| MCC950 |
MCC950 |
210826-40-7 |
| T-1095 |
T-1095 |
209746-59-8 |
| CONIVAPTAN |
CONIVAPTAN |
210101-16-9 |
| Tafluprost ethyl ester |
Tafluprost ethyl ester |
209860-89-9 |
| 9ALPHA,11ALPHA-DIHYDROXY-15,15-DIFLUORO-16-PHENOXY-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID |
他氟前列素酸 |
209860-88-8 |
| TF-BF |
2H-环戊并[B]呋喃-2-酮,5-(苯甲酰氧基)-4-[(1E)-3,3-二氟-4-苯氧基-丁烯-1-基]六氢-,(3AR,4R,5R,6AS)-(...) |
209861-00-7 |
| SU5402 |
2-[(1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-4-甲基-1H-吡咯-3-丙酸 |
215543-92-3 |
| CASPASE-8 INHIBITOR II |
CASPASE-8抑制剂 |
210344-98-2 |
| RAF709 |
化合物RAF709 |
1628838-42-5 |
| 1-(4-(5-(5-amino-6-(5-(tert-butyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one |
AZD-8835 |
1620576-64-8 |
| 5-(5-methyl-1-(3-(4-(methylsulfonyl)piperidin-1-yl)benzyl)-1H-1,2,4-triazol-3-yl)-3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole |
5-(5-甲基-1-(3-(4-(甲基磺酰基)哌啶-1-基)苄基)-1H-1,2,4-三唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑 |
1570496-34-2 |
| Gon-5-en-3-one, 13-ethyl-17-hydroxy-11-methylene-, cyclic 1,2-ethanediylacetal |
Gon-5-en-3-one, 13-ethyl-17-hydroxy-11-methylene-, cyclic 1,2-ethanediylacetal |
1574323-08-2 |
| SEP-0372814 |
SEP-0372814 |
1516895-53-6 |
| (S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
(S)-1-(3-methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one |
1523404-29-6 |
| dasabuvir sodium hydrate |
达沙布韦钠 |
1456607-55-8 |
| RK-20449 trihydrochloride |
7-[反式-4-(4-甲基-1-哌嗪基)环己基]-5-(4-苯氧基苯基)-7H-吡咯并[2,3-D]嘧啶-4-胺三盐酸盐 |
1435934-25-0 |
| LDN 193189 hydrochloride |
LDN-193189 2HCL |
1435934-00-1 |
| GSK-LSD1 |
GSK-LSD1 |
1431368-48-7 |
| 1A-116 |
1A-116 |
1430208-73-3 |
| KPT-330, (E)-RN |
(E)-3-(3-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-1-YL)-N'-(PYRAZIN-2-YL)ACRYLOHYDRAZIDE |
1421923-86-5 |
QQ
微信
